Thomas Royce
Papers
1
Total Citations
7
H-Index
1
About
Thomas Royce is a pathologist whose work bridges rare tumor diagnostics and cutting-edge genomic technology. His primary research focuses on the histopathological and molecular characterization of uncommon neoplasms, with a particular emphasis on gastrointestinal and perivascular tumors. Royce’s most notable contribution is his 2017 study, “Micrometastatic gastric glomus tumour confirmed by next‐generation sequencing,” which, despite its modest citation count of 7, represents a landmark in precision pathology. In this work, he demonstrated how next-generation sequencing can definitively identify micrometastatic glomus tumors—rare perivascular neoplasms typically found in the dermis—when conventional histology proves ambiguous. This case report underscored the diagnostic power of molecular tools in challenging clinical scenarios, offering a template for integrating genomics into routine pathology workflows. Royce’s broader impact lies in advancing the understanding of glomus tumor biology and metastatic behavior, providing clinicians with more accurate diagnostic frameworks. His meticulous approach to rare tumors has earned him recognition among surgical pathologists and molecular diagnosticians, positioning him as a key figure in the evolving landscape of personalized cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1